Foamix Pharmaceuticals

Foamix Pharmaceuticals is a dynamic pharmaceutical company dedicated to the development and commercialization of innovative topical foams, addressing critical unmet needs in the field of dermatology. With a focus on creating proprietary solutions, Foamix Pharmaceuticals is committed to advancing patient care through cutting-edge research and development.

Located at 2 Holzman Street, Weizmann Science Park, Rehovot, 76704, IL, with an additional location at 520 U.S. Highway 22, Suite 204, Bridgewater, NJ 520, US, Foamix Pharmaceuticals is strategically positioned to serve the global market. The company's clinical-stage product candidates, including FMX101 for moderate-to-severe acne and FMX103 for moderate-to-severe rosacea, highlight its commitment to addressing prevalent dermatological conditions.

Foamix Pharmaceuticals continues to expand its capabilities and impact in the pharmaceutical industry, driven by a passion for innovation and a dedication to improving patient outcomes. We invite the manager of Foamix Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.